Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices

被引：11

作者：

Dhruva, Sanket S. ^{[1
,2
,3
]}

Mazure, Carolyn M. ^{[4
,5
]}

Ross, Joseph S. ^{[1
,6
,7
,8
]}

Redberg, Rita F. ^{[9
,10
]}

机构：

[1] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St,SHM I-456,POB 208088, New Haven, CT 06520 USA

[2] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA

[3] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA

[4] Yale Sch Med, Dept Psychiat, New Haven, CT USA

[5] Yale Sch Med, Womens Hlth Res Yale, New Haven, CT USA

[6] Yale Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT USA

[7] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA

[8] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA

[9] Univ Calif San Francisco, Dept Med, Div Cardiol, Sch Med, San Francisco, CA 94143 USA

[10] Univ Calif San Francisco, Sch Med, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA

来源：

JAMA INTERNAL MEDICINE | 2017年 / 177卷 / 09期

关键词：

D O I：

10.1001/jamainternmed.2017.3148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1390 / 1391

页数：3

共 50 条

[21] Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
Dubin, Jonathan R.
Simon, Stephen D.
Norrell, Kirsten
Perera, Jacob
Gowen, Jacob
Cil, Akin
[J]. JAMA NETWORK OPEN, 2021, 4 (05)
[22] High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
Pathak, Kavya
Narang, Claire
Hwang, Thomas J.
Espinoza, Juan C.
Bourgeois, Florence T.
[J]. JAMA PEDIATRICS, 2023, 177 (01) : 98 - 100
[23] Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019
Talati, Ish A.
Parsa, Keon M.
Gao, William Z.
[J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 167 (05) : 832 - 838
[24] Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices
Dhruva, Sanket S.
Bero, Lisa A.
Redberg, Rita F.
[J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (02): : 165 - U49
[25] High-risk Medical Devices Variable evidence after approval Comment
Zens, Yvonne
[J]. PNEUMOLOGIE, 2016, 70 (02): : 80 - 80
[26] Assessing the Safety and Effectiveness of Devices After US Food and Drug Administration Approval FDA-Mandated Postapproval Studies
Reynolds, Ian S.
Rising, Joshua P.
Coukell, Allan J.
Paulson, Kirsten H.
Redberg, Rita F.
[J]. JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1773 - 1779
[27] The US Food and Drug Administration 515 Program Initiative Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices?
Rathi, Vinay K.
Kesselheim, Aaron S.
Ross, Joseph S.
[J]. JAMA CARDIOLOGY, 2016, 1 (02) : 117 - 118
[28] U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis
Deisseroth, Albert
Kaminskas, Edvardas
Grillo, Joseph
Chen, Wei
Saber, Haleh
Lu, Hong L.
Rothmann, Mark D.
Brar, Satjit
Wang, Jian
Garnett, Christine
Bullock, Julie
Burke, Laurie B.
Rahman, Atiqur
Sridhara, Rajeshwari
Farrell, Ann
Pazdur, Richard
[J]. CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3212 - 3217
[29] IOM, US Food and Drug Administration to study clearance process for medical devices
Naditz, Alan
[J]. TELEMEDICINE JOURNAL AND E-HEALTH, 2009, 15 (10): : 916 - 916
[30] Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014
Rathi, Vinay K.
Wang, Bo
Ross, Joseph S.
Downing, Nicholas S.
Kesselheim, Aaron S.
Gray, Stacey T.
[J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (04) : 683 - 692

← 1 2 3 4 5 →